Camelids for COVID

Human monoclonal antibodies that block infection with SARS-CoV-2 are being used to treat COVID-19 patients, but an alternative, antibodies produced in camelids (alpacas and llamas) might have advantages. Camelid monoclonal antibodies can be more cheaply produced in mass quantities in bacteria, and protein engineering can be quickly used to produce a better therapeutic product. Human […]
Source: virology blog - Category: Virology Authors: Tags: Basic virology Information camelid coronavirus COVID-19 monoclonal antibody pandemic SARS-CoV-2 viral viruses Source Type: blogs